Nitric Oxide Clobbers Sars-Cov2: Clinical Trial Confirms Breakthrough Treatment for COVID-19

Yet another safe, cheap and effective treatment. But be sure to stay muzzled in your isolation chamber until you get medicine’s latest tinker-toy tech injected into you.

Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours

Trial concluded that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo

Randomized, double-blind, placebo-controlled trial evaluated 79 confirmed cases of COVID-19, the majority heavily-infected with the UK variant

No adverse events were recorded in the group

Submission for Emergency Use in the UK and Canada for the treatment and prevention of COVID-19 is planned immediately

Biotech company SaNOtize Research & Development Corp., (SaNOtize), Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, and Berkshire and Surrey Pathology Services, UK, on Thursday announced results of clinical trials indicating that SaNOtize’s Nitric Oxide Nasal Spray (NONS) represents a safe and effective antiviral treatment that could prevent the transmission of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those already infected….

https://www.globalresearch.ca/clinical-trial-confirms-breakthrough-treatment-covid-19/5743173

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.